Assessment of Clinically Relevant Drug Interactions by Online Programs in Renal Transplant Recipients

---

Tecen-Yucel K., Bayraktar-Ekincioglu A., YILDIRIM T., YILMAZ Ş. R., Demirkan K., ERDEM Y.

JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, vol.26, no.10, pp.1291-1296, 2020 (SCI-Expanded, Scopus)

• Publication Type: Article / Article
• Volume: 26 Issue: 10
• Publication Date: 2020
• Doi Number: 10.18553/jmcp.2020.26.10.1291
• Journal Name: JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
• Page Numbers: pp.1291-1296
• Open Archive Collection: AVESIS Open Access Collection
• Hacettepe University Affiliated: Yes

Abstract

BACKGROUND: Potential drug-drug interactions (pDDIs) with immunosuppressive drugs are frequently observed in renal transplant recipients. Drug interaction programs are acknowledged as a fundamental tool to alert physicians to pDDIs, but there is a high concern about variation among different programs in terms of quality and reliability of information.